Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes

Annals of Oncology

Volumn 18, Issue 3, 2007, Pages 535-540

  Song, K W ^a   Barnett, M J ^a   Gascoyne, R D ^a   Chhanabhai, M ^a   Forrest, D L ^a   Hogge, D E ^a   Lavoie, J C ^a   Nantel, S H ^a   Nevill, T J ^a   Shepherd, J D ^a   Smith, C A ^a   Sutherland, H J ^a   Toze, C L ^a   Voss, N J ^a   Connors, J M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Acute lymphoblastic leukemia; Lymphoblastic lymphoma; Stem cell transplant; T cell lymphoma

Indexed keywords

ACICLOVIR; AMPHOTERICIN; ASPARAGINASE; CARMUSTINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUCONAZOLE; HEPARIN; MELPHALAN; METHOTREXATE; PENTAMIDINE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW METASTASIS; CANADA; CANCER REGRESSION; CANCER SURVIVAL; CHEMOSENSITIVITY; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; LYMPHOBLASTOMA; MALE; MYCOSIS; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PNEUMOCYSTOSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; VEIN OCCLUSION; WHOLE BODY RADIATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRITISH COLUMBIA; CHEMOTHERAPY, ADJUVANT; DATABASES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHOMA, LYMPHOBLASTIC; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PRACTICE GUIDELINES; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33847637697     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl426     Document Type: Article

References (18)

1. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997; 89: 3909-3918.
2. Harris NL, Jaffe ES, Diebold J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-3849.
3. Hoelzer D, Gokbuget N. Treatment of lymphoblastic lymphoma in adults. Best Pract Res Clin Haematol 2003; 15: 713-728.
4. Mora J, Filippa DA, Qin J et al. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: The 30-year experience at Memorial-Sloan-Kettering Cancer Center. Cancer 2003; 98: 1283-1291.
5. Reiter A, Schrappe M, Ludwig WD et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: A BFM group report. Blood 2000; 95: 416-421.
6. Thomas DA, O'Brien S, Cortes J et al. Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood 2004; 104: 1624-1630.
7. Hoelzer D, Gokbuget N, Digel W et al. Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood 2002; 99: 4379-4385.
8. Verdonck LF, Dekker AW, de Gast GC et al. Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission. J Clin Oncol 1992; 10: 644-646.
9. Santini G, Coser P, Chisesi T et al. Autologous bone marrow transplantation for advanced stage adult lymphoblastic lymphoma in first complete remission. A pilot study of the non-Hodgkin's Lymphoma Co-operative Study Group (NHLCSG). Bone Marrow Transplant 1989; 4: 399-404.
10. Sweetenham JW, Liberti G, Pearce R et al. High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: Results of the European Group for Bone Marrow Transplantation. J Clin Oncol 1994; 12: 1358-1365.
11. Bouabdallah R, Xerri L, Bardou VJ et al. Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: A report on 62 patients from a single center. Ann Oncol 1998; 9: 619-625.
12. Carbone PP, Kaplan HS, Musshoff K et al. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971; 31: 1860-1861.
13. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53157-181.
14. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987-994.
15. Sweetenham JW, Santini G, Qian W et al. High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/ maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: Results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group. J Clin Oncol 2001; 19: 2927-2936.
16. Milpied N, Ifrah N, Kuentz M et al. Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission. Br J Haematol 1989; 73: 82-87.
17. Levine JE, Harris RE, Loberiza FR Jr et al. A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood 2003; 101: 2476-2482.
18. Pedersen-Bjergaard J, Andersen MK, Christiansen DH. Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation. Blood 2000; 95: 3273-3279.